CoChat

Split intein-mediated protein trans-splicing to express large dystrophins

Tasfaout, Hichem, Halbert, Christine L., McMillen, Timothy S., Allen, James M., Reyes, Theodore R., Flint, Galina V., Grimm, Dirk, Hauschka, Stephen D., Regnier, Michael, Chamberlain, Jeffrey S. · 2024 · Nature

Published version of a preprint

Cited by 83

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-024-07710-8

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 40

  1. Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V. & Rizvanov, A. A. Various AAV serotypes and their applications in gene therapy: an overview. Cells 12, 785 (2023). · DOI · Paper page
  2. Monaco, A. P. et al. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 316, 842–845 (1985). · DOI · Paper page
  3. Kunkel, L. M. et al. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 322, 73–77 (1986). · DOI · Paper page
  4. Danialou, G. et al. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 15, 1655–1657 (2001). · DOI · Paper page
  5. Ervasti, J. M. & Campbell, K. P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121–1131 (1991). · DOI · Paper page
  6. Ervasti, J. M. & Campbell, K. P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809–823 (1993). · DOI · Paper page
  7. Banks, G. B., Judge, L. M., Allen, J. M. & Chamberlain, J. S. The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins. PLoS Genet. 6, e1000958 (2010). · DOI · Paper page
  8. Gregorevic, P. et al. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat. Med. 12, 787–789 (2006). · DOI · Paper page
  9. Ramos, J. N. et al. Development of novel micro-dystrophins with enhanced functionality. Mol. Ther. 27, 623–635 (2019). · DOI · Paper page
  10. Bostick, B. et al. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J. Mol. Cell. Cardiol. 53, 217–222 (2012). · DOI · Paper page
  11. Harper, S. Q. et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8, 253–261 (2002). · DOI · Paper page
  12. Wasala, L. P. et al. The implication of hinge 1 and hinge 4 in micro-dystrophin gene therapy for Duchenne muscular dystrophy. Hum. Gene Ther. https://doi.org/10.1089/hum.2022.180 (2022). · DOI
  13. Birch, S. M. et al. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Sci. Transl. Med. 15, eabo1815 (2023). · DOI
  14. Esposito, F. et al. Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A. EMBO Mol. Med. 14, e15199 (2022). · DOI
  15. Li, Y. F. Split-inteins and their bioapplications. Biotechnol. Lett 37, 2121–2137 (2015). · DOI
  16. Padula, A. et al. Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice. Mol. Ther. Methods Clin. Dev. 26, 495–504 (2022). · DOI
  17. Li, J., Sun, W. C., Wang, B., Xiao, X. & Liu, X. Q. Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. Hum. Gene Ther. 19, 958–964 (2008). · DOI · Paper page
  18. Carvajal-Vallejos, P., Pallissé, R., Mootz, H. D. & Schmidt, S. R. Unprecedented rates and efficiencies revealed for new natural split inteins from metagenomic sources. J. Biol. Chem. 287, 28686–28696 (2012). · DOI · Paper page
  19. Caspi, J., Amitai, G., Belenkiy, O. & Pietrokovski, S. Distribution of split DnaE inteins in cyanobacteria. Mol. Microbiol. 50, 1569–1577 (2003). · DOI · Paper page
  20. Shah, N. H., Dann, G. P., Vila-Perelló, M., Liu, Z. H. & Muir, T. W. Ultrafast protein splicing is common among cyanobacterial split inteins: implications for protein engineering. J. Am. Chem. Soc. 134, 11338–11341 (2012). · DOI · Paper page
  21. Abedi, M. R., Caponigro, G. & Kamb, A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res. 26, 623–630 (1998). · DOI · Paper page
  22. Crudele, J. M. & Chamberlain, J. S. AAV-based gene therapies for the muscular dystrophies. Hum. Mol. Genet. 28, R102–R107 (2019). · DOI · Paper page
  23. Boer, J. M., de Meijer, E. J., Mank, E. M., van Ommen, G. B. & den Dunnen, J. T. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mice. Neuromuscul. Disord. 12, S118–S124 (2002). · DOI
  24. Torres, L. F. B. & Duchen, L. W. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110, 269–299 (1987). · DOI · Paper page
  25. Bengtsson, N. E., Tasfaout, H., Hauschka, S. D. & Chamberlain, J. S. Dystrophin gene-editing stability is dependent on dystrophin levels in skeletal but not cardiac muscles. Mol. Ther. 29, 1070–1085 (2021). · DOI
  26. Lynch, G. S., Hinkle, R. T., Chamberlain, J. S., Brooks, S. V. & Faulkner, J. A. Force and power output of fast and slow skeletal muscles from mdx mice 6–28 months old. J. Physiol. 535, 591–600 (2001). · DOI · Paper page
  27. Pastoret, C. & Sebille, A. Mdx mice show progressive weakness and muscle deterioration with age. J. Neurol. Sci. 129, 97–105 (1995). · DOI · Paper page
  28. Stedman, H. H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536–539 (1991). · DOI · Paper page
  29. Lefaucheur, J. P., Pastoret, C. & Sebille, A. Phenotype of dystrophinopathy in old mdx mice. Anat. Rec. 242, 70–76 (1995). · DOI · Paper page
  30. Chamberlain, J. S., Metzger, J., Reyes, M., Townsend, D. W. & Faulkner, J. A. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 21, 2195–2204 (2007). · DOI · Paper page
  31. El Andari, J. et al. Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders. Sci. Adv. 8, eabn4704 (2022). · DOI
  32. Tabebordbar, M. et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184, 4919–4938.e22 (2021). · DOI · Paper page
  33. Hartigan-O’Connor, D., Kirk, C. J., Crawford, R., Mule, J. J. & Chamberlain, J. S. Immune evasion by muscle-specific gene expression in dystrophic muscle. Mol. Ther. 4, 525–533 (2001). · DOI · Paper page
  34. Boennemann, C. G. et al. Dystrophin immunity after gene therapy for Duchenne’s muscular dystrophy. N. Engl. J. Med. 388, 2294–2296 (2023). · DOI
  35. Halbert, C. L., Allen, J. M. & Chamberlain, J. S. AAV6 vector production and purification for muscle gene therapy. Methods Mol. Biol. 1687, 257–266 (2018). · DOI
  36. Dellorusso, C., Crawford, R. W., Chamberlain, J. S. & Brooks, S. V. Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J. Muscle Res. Cell Motil. 22, 467–475 (2001). · DOI · Paper page
  37. Gregorevic, P., Plant, D. R., Leeding, K. S., Bach, L. A. & Lynch, G. S. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am. J. Pathol. 161, 2263–2272 (2002). · DOI
  38. Kolwicz, S. C., Jr. & Tian, R. Assessment of cardiac function and energetics in isolated mouse hearts using 31P NMR spectroscopy. J. Vis. Exp. https://doi.org/10.3791/2069 (2010). · DOI
  39. Kolwicz, S. C. Jr. et al. Gene therapy rescues cardiac dysfunction in Duchenne muscular dystrophy mice by elevating cardiomyocyte deoxy-adenosine triphosphate. JACC Basic Transl. Sci. 4, 778–791 (2019). · DOI
  40. Rafael, J. A. et al. Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134, 93–102 (1996). · DOI · Paper page

Cited by

See all 83

Metadata

Authors
Tasfaout, H., Halbert, C. L., McMillen, T. S., Allen, J. M., Reyes, T. R., Flint, G. V., Grimm, D., Hauschka, S. D., Regnier, M., & Chamberlain, J. S.
Venue
Nature
Published
2024-07-17
Volume
632
Issue
8023
Pages
192-200
ISSN
  • 0028-0836
  • 1476-4687
Cited by
83
References
15
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Split intein-mediated protein trans-splicing to express large dystrophins. https://app.cochat.ai/papers/10.1038/s41586-024-07710-8
The paper
Tasfaout, H., Halbert, C. L., McMillen, T. S., Allen, J. M., Reyes, T. R., Flint, G. V., Grimm, D., Hauschka, S. D., Regnier, M., & Chamberlain, J. S. (2024). Split intein-mediated protein trans-splicing to express large dystrophins. Nature. https://doi.org/10.1038/s41586-024-07710-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.